Date:30-Mar-2010
New York Biotechnology Association (NYBA), the voice of New York State’s biotechnology industry, today announced the full program for the NYBA 2010 Annual Meeting, April 19-20, at the Marriott Marquis Hotel in New York City. Speakers representing more than 100 companies will discussion the issues and opportunities available to New York’s bioscience industry.
The NYBA 2010 Annual Meeting program, which can be seen at www.nyba.org, will highlight more than 30 panel sessions on key industry topics, including Drugs, Diagnostics and Medical Devices; Advances in Bioscience; Investment and Financial Issues; The Business of Biotech; Regulatory and Policy Challenges; and Legal and IP Issues.
Session highlights include:
- India and China: The Biotechnology Industry's Growing Powers
- Working With Science Not-For-Profits: A Solid Strategy For Marketing And Branding Your Corporation
- Sound Market Due Diligence Drives Deal Value-Strategies To Increase The Attractiveness Of Your Development-Stage Product To Potential Suitors
- What Early And Mid-Stage Biotech Companies Need To Know About The "New FDA" And How The Obama Administration Is Remaking FDA
- Wall Street Unplugged: Communicating With Wall Street
· Natural Selection In The Pharma Industry: Biotech Versus Big Pharma, Who Eats Whom?
· The New Normal In Biotech: A Strategic Approach To The Current Investing And Operating Environment
- Agriculture And Biotechnology: The Future Of Food, Fiber And Fuel
- In Re Bilski, Prometheus V Mayo, And ACLU V Myriad: How Current Cases Are Impacting The Patent-Eligibility Of Biotech Inventions
- Are New Yorl And It's Universities Doing Enough to Commercialize Academic Technologies?
In addition, the program will feature keynote addresses from
- Dr. Christoph Hergersberg, Global Leader of GE Bioscience;
- The Honorable Jim Greenwood, President and CEO of the Biotechnology Industry Organization;
- Gov. Howard Dean, Presidential candidate and 6-time governor of Vermont;
- Jerome Bettis, Super Bowl champion Pittsburgh Steelers running back and asthma health advocate; and
- Robert Lieber, Deputy Mayor of New York City for Economic Development.
Concurrently, in the Innovation Alley Poster Session, the next generation of scientists and emerging companies will exhibit their groundbreaking scientific research, work that will enable the next great bioscience discovery.
And in the Corporate Showcase, CEOs and top executives from more than 20 leading public and private companies will present their businesses to potential investors, strategic partners, customers and partners.
In all, more than 650 attendees will converge on the Marriott Marquis Hotel in Times Square to learn, network, discuss, contemplate, debate and engage. Confirmed attendees include executives from Aastrom Biosciences; Abiant; Acorda; Alexandria Real Estate; Alzheimer’s Drug Discovery Foundation; Antisoma; Aperion; Aureon; Bloomberg Equity Research; Cantor Fitzgerald; Celgene; Credit Suisse; FDA; Forest Labs; Goldman Sachs; HillCo Health; Hoffman-La Roche; Intra-Cellular Therapeutics; JP Morgan; Kolltan Pharmaceuticals; Nanomed Devices; Needham; Neostem; Novartis; OrbiMed; OSI Pharmaceuticals; Pfizer; Sanofi-Aventis; Scisive; US-India Business Council; World Intellectual Property Organization, and many, many more.
The NYBA Annual Meeting brings together hundreds of bioscience professionals from the New York, the Northeast and the world for two days of high-energy insight and information. For more information go to www.nyba.org or contact Patricia Waddington, NYBA Membership Director, at 631-444-8895.
|
